Manejo de la infección por Helicobacter pylori en atención primaria en España

Marshall, 1984, Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration, Lancet, 1, 1311, 10.1016/S0140-6736(84)91816-6 Goodwin, 1986, Campylobacter pyloridis, gastritis, and peptic ulceration, J Clin Pathol, 39, 353, 10.1136/jcp.39.4.353 Marshall, 1995, The 1995 Albert Lasker Medical Research Award. Helicobacter pylori. The etiologic agent for peptic ulcer, JAMA, 274, 1064, 10.1001/jama.1995.03530130070032 Forbes, 1994, Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up, Lancet, 343, 258, 10.1016/S0140-6736(94)91111-8 Van der Hulst, 1997, Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study, Gastroenterology, 113, 1082, 10.1053/gast.1997.v113.pm9322501 Malfertheiner, 2002, Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report, Aliment Pharmacol Ther, 16, 167, 10.1046/j.1365-2036.2002.01169.x Mones, 2005, Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference, Rev Esp Enferm Dig, 97, 348, 10.4321/S1130-01082005000500007 Gisbert, 2000, Tratamiento erradi cador de Helicobacter pylori. Recomendaciones de la Conferen cia Española de Consenso, Med Clin (Barc), 114, 185, 10.1016/S0025-7753(00)71237-1 Howden, 1998, Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology, Am J Gastroenterol, 93, 2330, 10.1111/j.1572-0241.1998.00684.x 1994, Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease, JAMA, 272, 65, 10.1001/jama.272.1.65 Azagra R, Barenys M, Benavent J, Bordas JM, Forne M, Mascort JJ. Guia de pràctica clínica per al diagnòstic i tractament dela dispèpsia i les malalties relacionades amb la infecció per Helicobacter pylori a l’atenció primària. Barcelona: Societat Catalana de Medicina Familiar i Comunitària i Societat Catalana de Digestologia; 2000, 2006. Gisbert, 2005, Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la II Conferencia Española de Consenso, Med Clin (Barc), 125, 301, 10.1157/13078424 Thamer, 1998, Influence of the NIH Consensus Conference on Helicobacter pylori on physician prescribing among a Medicaid population, Med Care, 36, 646, 10.1097/00005650-199805000-00005 Lee, 2000, Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice, Eur J Gastroenterol Hepatol, 12, 433, 10.1097/00042737-200012040-00011 Breuer, 1998, How do clinicians practicing in the US manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians, Am J Gastroenterol, 93, 553, 10.1111/j.1572-0241.1998.164_b.x Martínez-Sánchez, 1998, Actitud de los médicos de atención pri maria del área metropolitana de Barcelona frente al diagnósti co y tratamiento de la infección por Helicobacter pylori en en fermedades gastroduodenales, Gastroenterol Hepatol, 21, 473 Gené, 2002, Manejo de la dispepsia, la enfermedad ulcerosa y la infección por Helicobacter pylori en atención primaria, Aten Primaria, 29, 486, 10.1016/S0212-6567(02)70618-5 Anuario de la Sanidad y del Medicamento en España. El Médico. Profesión y Humanidades. 2005. p. 949. Calvet, 2005, Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial, Am J Gastroenterol, 100, 1696, 10.1111/j.1572-0241.2005.50019.x Fendrick, 1996, Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease, Am J Gastroenterol, 91, 1544 Azagra, 2000, Beneficios del tratamiento erradicador de la infección por Helicobacter pylori en pacientes ulcerosos en un centro de atención primaria, Aten Primaria, 25, 377, 10.1016/S0212-6567(00)78526-X Breuer, 1998, How do practicing clinicians manage Helicobacter pylori-related gastrointestinal diseases in Germany? A survey of gastroenterologists and family practitioners, Helicobacter, 3, 1, 10.1046/j.1523-5378.1998.08027.x Hirth, 1996, Specialist and genera list physicians’ adoption of antibiotic therapy to eradicate Helicobacter pylori infection, Med Care, 34, 1199, 10.1097/00005650-199612000-00005 Hobbs, 1996, Effect of Helicobacter pylori eradication therapy on dyspeptic symptoms in primary care, Fam Pract, 13, 225, 10.1093/fampra/13.3.225 Weijnen, 2001, Dyspepsia management in primary care in The Netherlands: to what extent is Helicobacter pylori diagnosis and treatment incorporated? Results from a survey among general practitio ners in The Netherlands, Digestion, 64, 40, 10.1159/000048837 Burget, 1990, Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression, Gastroenterology, 99, 345, 10.1016/0016-5085(90)91015-X Castell, 2002, Esomeprazole (40mg) compared with lansoprazole (30mg) in the treatment of erosive esophagitis, Am J Gastroenterol, 97, 575, 10.1111/j.1572-0241.2002.05532.x Smith, 2003, Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors, Gastrointest Endosc, 58, 9, 10.1067/mge.2003.308 Gisbert, 2002, Estudio de la validez de la serología «rápida» para el estudio de la infección por Helicobacter pylori, Aten Primaria, 30, 501, 10.1016/S0212-6567(02)79087-2 Phull, 1996, Absence of dys peptic symptoms as a test of Helicobacter pylori eradication, BMJ, 312, 349, 10.1136/bmj.312.7027.349 Gené, 2000, Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers: a cost-effectiveness analysis, Aliment Pharmacol Ther, 14, 433, 10.1046/j.1365-2036.2000.00735.x